October 26, 2004 |
Elan Corp., Ireland's biggest drug maker, said it would pay $75 million to settle a shareholder lawsuit and a $15-million fine to resolve a Securities and Exchange Commission complaint related to the company's accounting. The company said $35 million of the settlement's cost would be covered by insurance. The company did not admit wrongdoing.
June 10, 2002 |
Elan Corp., a Dublin-based drug maker whose shares have declined 88% in the last year, plans to exit from businesses and cut its locations by half in response to investor pressure, the Sunday Times reported, citing Chairman and Chief Executive Donal Geaney. Elan today will say it plans to focus on two of its five product areas, neurology and pain killers, and quit acute care, cancer treatment and dermatology, the newspaper said.
September 12, 2000 |
Fast-growing pharmaceutical company Elan Corp. said Monday that it was boosting its U.S. presence through a $1.8-billion stock deal to buy San Diego-based Dura Pharmaceuticals Inc. Dura markets and sells prescription products that treat infectious diseases and respiratory conditions. Elan, whose headquarters are in Dublin, Ireland, and whose U.S. operations are based in San Diego, said the deal would add $300 million in revenue in 2001 and double the size of its U.S.
November 8, 2002
Elan Corp., a struggling Irish drug company, has ended its collaboration with Isis Pharmaceuticals of Carlsbad to develop a drug to treat hepatitis C.
CALIFORNIA | LOCAL
May 16, 2000
On Assignment Inc., Calabasas, has been added to the Standard & Poor's Small Cap 600 Index, replacing Liposome Co., which has been acquired by Elan Corp. based in Ireland. On Assignment Inc. provides temporary staffing services to the scientific, health care and environmental industries.